Please enable JavaScript to continue using this application.

Compare $AVXL vs $TNXP | Chartloom

Compare

$AVXL vs $TNXP

Anavex Life Sciences Corp · Tonix Pharmaceuticals Holding Corp

AVXL

Anavex Life Sciences Corp

TNXP

Tonix Pharmaceuticals Holding Corp

Compare $AVXL vs $TNXP

Comparing Anavex Life Sciences Corp and Tonix Pharmaceuticals Holding Corp

AVXLAnavex Life Sciences Corp

TNXPTonix Pharmaceuticals Holding Corp

AVXLAnavex Life Sciences Corp

Market cap

$138M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-59.5%

52W performance

-84.9%

FCF yield

-21.2%

TNXPTonix Pharmaceuticals Holding Corp

Market cap

$116M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.39x

Rev growth (TTM)

196.0%

YTD performance

-55.9%

52W performance

-67.5%

FCF yield

-135.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AVXL

TNXP

Detailed metrics comparison

AVXL

Anavex Life Sciences Corp

TNXP

Tonix Pharmaceuticals Holding Corp

Market Cap

AVXL$138M

TNXP$116M

Enterprise Value

AVXL$20M

TNXP$-60M

Price

AVXL$1.49

TNXP$7.30

P/E Ratio

AVXLN/A

TNXPN/A

P/S Ratio

AVXL0.00x

TNXP4.00x

EV/Sales

AVXL0.00x

TNXP-2.06x

EV/EBITDA

AVXL0.00x

TNXP0.00x

P/B Ratio

AVXL1.50x

TNXP0.69x

P/FCF Ratio

AVXLN/A

TNXPN/A

EV/FCF

AVXL-0.67x

TNXP0.38x

PEG Ratio

AVXLN/A

TNXPN/A

Forward P/E (NTM)

AVXLN/A

TNXPN/A

Forward P/S (NTM)

AVXLN/A

TNXP1.39x

Revenue (TTM)

AVXL$0

TNXP$29M

Revenue Growth (YoY)

AVXLN/A

TNXP196.0%

Forward Rev Growth

AVXL377.5%

TNXP101.6%

Gross Margin (TTM)

AVXL0.0%

TNXP83.8%

Operating Margin (TTM)

AVXL0.0%

TNXP0.0%

EBITDA Margin (TTM)

AVXL0.0%

TNXP-561.1%

Net Margin (TTM)

AVXL0.0%

TNXP-548.6%

FCF Margin (TTM)

AVXLN/A

TNXP-543.3%

Net Income (TTM)

AVXL$-13M

TNXP$-160M

FCF (TTM)

AVXL$-29M

TNXP$-158M

EPS (TTM)

AVXL-$0.14

TNXP-$9.60

ROE (TTM)

AVXL-1143.0%

TNXP-6899.0%

ROA (TTM)

AVXL-1072.0%

TNXP-6132.0%

ROIC (TTM)

AVXL-1143.0%

TNXP-6899.0%

Cash

AVXL$118M

TNXP$176M

Debt

AVXL$0

TNXP$0

Net Cash/Debt

AVXL$118M

TNXP$176M

Current Ratio (TTM)

AVXL15.62x

TNXP6.61x

Quick Ratio (TTM)

AVXL15.51x

TNXP6.13x

Debt/Equity (TTM)

AVXL0.00x

TNXP0.00x

Debt/Assets (TTM)

AVXL0.0%

TNXP0.0%

Interest Coverage (TTM)

AVXLN/A

TNXPN/A

Net Debt/EBITDA (TTM)

AVXL0.00x

TNXP0.00x

Beta

AVXL1.20

TNXP1.87

52W Performance

AVXL-84.9%

TNXP-67.5%

YTD Performance

AVXL-59.5%

TNXP-55.9%

% from 52W High

AVXL-85.0%

TNXP-68.3%

% from 52W Low

AVXL3.5%

TNXP3.0%

Asset Turnover (TTM)

AVXL0.00x

TNXP0.11x

FCF Yield (TTM)

AVXL-21.2%

TNXP-135.9%

Earnings Yield (TTM)

AVXL-9.4%

TNXP-137.2%

Dividend Yield (TTM)

AVXLN/A

TNXPN/A

Rule of 40

AVXL0.0

TNXP-347.3

EV/GP/RG

AVXLN/A

TNXPN/A

Ticker research

View AVXL research View TNXP research

Metric	AVXL Anavex Life Sciences Corp	TNXP Tonix Pharmaceuticals Holding Corp
Market & Valuation
Market Cap	$138M	$116M
Enterprise Value	$20M	$-60M
Price	$1.49	$7.30
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	4.00x
EV/Sales	0.00x	-2.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	0.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	0.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.39x
Revenue & Growth
Revenue (TTM)	$0	$29M
Revenue Growth (YoY)	N/A	196.0%
Forward Rev Growth	377.5%	101.6%
Profitability
Gross Margin (TTM)	0.0%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-561.1%
Net Margin (TTM)	0.0%	-548.6%
FCF Margin (TTM)	N/A	-543.3%
Net Income (TTM)	$-13M	$-160M
FCF (TTM)	$-29M	$-158M
EPS (TTM)	-$0.14	-$9.60
ROE (TTM)	-1143.0%	-6899.0%
ROA (TTM)	-1072.0%	-6132.0%
ROIC (TTM)	-1143.0%	-6899.0%
Financial Health
Cash	$118M	$176M
Debt	$0	$0
Net Cash/Debt	$118M	$176M
Current Ratio (TTM)	15.62x	6.61x
Quick Ratio (TTM)	15.51x	6.13x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	1.87
52W Performance	-84.9%	-67.5%
YTD Performance	-59.5%	-55.9%
% from 52W High	-85.0%	-68.3%
% from 52W Low	3.5%	3.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.11x
FCF Yield (TTM)	-21.2%	-135.9%
Earnings Yield (TTM)	-9.4%	-137.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-347.3
EV/GP/RG	N/A	N/A
Ticker research	View AVXL research	View TNXP research

Valuation

P/S Ratio

AVXL

0.00x

TNXP

4.00x

EV/FCF

AVXL

-0.67x

TNXP

0.38x

Growth & revenue

Revenue Growth TTM

TNXP

196.0%

Forward Revenue Growth

AVXL

377.5%

TNXP

101.6%

Profitability & performance

Gross Margin

TNXP

83.8%

AVXL

0.0%

ROE

AVXL

-1143.0%

TNXP

-6899.0%

FCF Yield %

AVXL

-21.2%

TNXP

-135.9%

52-Week Performance

TNXP

-67.5%

AVXL

-84.9%

Detailed metrics comparison

AVXL

Anavex Life Sciences Corp

TNXP

Tonix Pharmaceuticals Holding Corp

Market Cap

AVXL$138M

TNXP$116M

Enterprise Value

AVXL$20M

TNXP$-60M

Price

AVXL$1.49

TNXP$7.30

P/E Ratio

AVXLN/A

TNXPN/A

P/S Ratio

AVXL0.00x

TNXP4.00x

EV/Sales

AVXL0.00x

TNXP-2.06x

EV/EBITDA

AVXL0.00x

TNXP0.00x

P/B Ratio

AVXL1.50x

TNXP0.69x

P/FCF Ratio

AVXLN/A

TNXPN/A

EV/FCF

AVXL-0.67x

TNXP0.38x

PEG Ratio

AVXLN/A

TNXPN/A

Forward P/E (NTM)

AVXLN/A

TNXPN/A

Forward P/S (NTM)

AVXLN/A

TNXP1.39x

Revenue (TTM)

AVXL$0

TNXP$29M

Revenue Growth (YoY)

AVXLN/A

TNXP196.0%

Forward Rev Growth

AVXL377.5%

TNXP101.6%

Gross Margin (TTM)

AVXL0.0%

TNXP83.8%

Operating Margin (TTM)

AVXL0.0%

TNXP0.0%

EBITDA Margin (TTM)

AVXL0.0%

TNXP-561.1%

Net Margin (TTM)

AVXL0.0%

TNXP-548.6%

FCF Margin (TTM)

AVXLN/A

TNXP-543.3%

Net Income (TTM)

AVXL$-13M

TNXP$-160M

FCF (TTM)

AVXL$-29M

TNXP$-158M

EPS (TTM)

AVXL-$0.14

TNXP-$9.60

ROE (TTM)

AVXL-1143.0%

TNXP-6899.0%

ROA (TTM)

AVXL-1072.0%

TNXP-6132.0%

ROIC (TTM)

AVXL-1143.0%

TNXP-6899.0%

Cash

AVXL$118M

TNXP$176M

Debt

AVXL$0

TNXP$0

Net Cash/Debt

AVXL$118M

TNXP$176M

Current Ratio (TTM)

AVXL15.62x

TNXP6.61x

Quick Ratio (TTM)

AVXL15.51x

TNXP6.13x

Debt/Equity (TTM)

AVXL0.00x

TNXP0.00x

Debt/Assets (TTM)

AVXL0.0%

TNXP0.0%

Interest Coverage (TTM)

AVXLN/A

TNXPN/A

Net Debt/EBITDA (TTM)

AVXL0.00x

TNXP0.00x

Beta

AVXL1.20

TNXP1.87

52W Performance

AVXL-84.9%

TNXP-67.5%

YTD Performance

AVXL-59.5%

TNXP-55.9%

% from 52W High

AVXL-85.0%

TNXP-68.3%

% from 52W Low

AVXL3.5%

TNXP3.0%

Asset Turnover (TTM)

AVXL0.00x

TNXP0.11x

FCF Yield (TTM)

AVXL-21.2%

TNXP-135.9%

Earnings Yield (TTM)

AVXL-9.4%

TNXP-137.2%

Dividend Yield (TTM)

AVXLN/A

TNXPN/A

Rule of 40

AVXL0.0

TNXP-347.3

EV/GP/RG

AVXLN/A

TNXPN/A

Ticker research

View AVXL research View TNXP research

Metric	AVXL Anavex Life Sciences Corp	TNXP Tonix Pharmaceuticals Holding Corp
Market & Valuation
Market Cap	$138M	$116M
Enterprise Value	$20M	$-60M
Price	$1.49	$7.30
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	4.00x
EV/Sales	0.00x	-2.06x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.50x	0.69x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.67x	0.38x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.39x
Revenue & Growth
Revenue (TTM)	$0	$29M
Revenue Growth (YoY)	N/A	196.0%
Forward Rev Growth	377.5%	101.6%
Profitability
Gross Margin (TTM)	0.0%	83.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-561.1%
Net Margin (TTM)	0.0%	-548.6%
FCF Margin (TTM)	N/A	-543.3%
Net Income (TTM)	$-13M	$-160M
FCF (TTM)	$-29M	$-158M
EPS (TTM)	-$0.14	-$9.60
ROE (TTM)	-1143.0%	-6899.0%
ROA (TTM)	-1072.0%	-6132.0%
ROIC (TTM)	-1143.0%	-6899.0%
Financial Health
Cash	$118M	$176M
Debt	$0	$0
Net Cash/Debt	$118M	$176M
Current Ratio (TTM)	15.62x	6.61x
Quick Ratio (TTM)	15.51x	6.13x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	1.87
52W Performance	-84.9%	-67.5%
YTD Performance	-59.5%	-55.9%
% from 52W High	-85.0%	-68.3%
% from 52W Low	3.5%	3.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.11x
FCF Yield (TTM)	-21.2%	-135.9%
Earnings Yield (TTM)	-9.4%	-137.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-347.3
EV/GP/RG	N/A	N/A
Ticker research	View AVXL research	View TNXP research